PROCEPT BioRobotics Corp. (PRCT)
24.70
-1.05
(-4.08%)
USD |
NASDAQ |
Nov 20, 16:00
24.74
+0.04
(+0.16%)
After-Hours: 20:00
PROCEPT BioRobotics Research and Development Expense (TTM) : 80.63M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 80.63M |
| June 30, 2026 | 78.81M |
| March 31, 2026 | 74.75M |
| December 31, 2025 | 69.69M |
| September 30, 2025 | 65.70M |
| June 30, 2025 | 62.83M |
| March 31, 2025 | 63.02M |
| December 31, 2024 | 58.52M |
| September 30, 2024 | 56.63M |
| June 30, 2024 | 51.86M |
| March 31, 2024 | 46.78M |
| Date | Value |
|---|---|
| December 31, 2023 | 44.32M |
| September 30, 2023 | 40.83M |
| June 30, 2023 | 36.42M |
| March 31, 2023 | 31.36M |
| December 31, 2022 | 26.92M |
| September 30, 2022 | 22.31M |
| June 30, 2022 | 21.09M |
| March 31, 2022 | 18.71M |
| December 31, 2021 | 18.22M |
| September 30, 2021 | 17.69M |
| June 30, 2021 | 16.66M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Beta Bionics, Inc. | 42.70M |
| Abbott Laboratories | 3.30B |
| Boston Scientific Corp. | 2.159B |
| Insulet Corp. | 360.30M |
| Baxter International, Inc. | 483.00M |